C31H38N2O13
Neat
646.65
1260613-88-4; Moexiprilat Acyl-|A-D-glucuronide, >65%; (2S, 3S, 4S, 5R, 6S)-6-[(3S)-2-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]propanoyl]-6, 7-dimethoxy-3, 4-dihydro-1H-isoquinoline-3-carbonyl]oxy-3, 4, 5-trihydroxyoxane-2-carboxylic acid; Moexiprilat Acyl-beta-D-glucuronide, >65per cent; DTXSID80858127; Moexiprilat Acyl-?-D-glucuronide, >65%; 1-O-[(3S)-2-{N-[(1S)-1-Carboxy-3-phenylpropyl]-L-alanyl}-6, 7-dimethoxy-1, 2, 3 and 4-tetrahydroisoquinoline-3-carbonyl]-beta-D-glucopyranuronic acid
(2S, 3S, 4S, 5R, 6S)-6-[(3S)-2-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]-6, 7-dimethoxy-3, 4-dihydro-1H-isoquinoline-3-carbonyl]oxy-3, 4 and 5-trihydroxyoxane-2-carboxylic acid
InChI=1S/C31H38N2O13/c1-15(32-19(28(38)39)10-9-16-7-5-4-6-8-16)27(37)33-14-18-13-22(44-3)21(43-2)12-17(18)11-20(33)30(42)46-31-25(36)23(34)24(35)26(45-31)29(40)41/h4-8,12-13,15,19-20,23-26,31-32,34-36H,9-11,14H2,1-3H3,(H,38,39)(H,40,41)/t15-,19-,20-,23-,24-,25+,26-,31-/m0/s1